Ariel Green, MD, MPH, PhD

Primary Academic Title

Associate Professor of Medicine

Background

Centers and Institutes

• Drug Safety and Effectiveness, Center for
• Transformative Geriatric Research, Center for

Recent News Articles and Media Coverage

• Aging and the Art of Losing, The New York Times (December 19, 2013)
• A young geriatrician on the struggles of Alzheimer’s patients – and their caretakers, The Washington Post (September 2, 2013)

Research Interests

dementia, Reducing use of potentially harmful medicines in older adults, shared decision making

Lab Website

Ariel Green Lab

• Research in the Ariel Green Lab focuses on informing and improving decisions surrounding the use of invasive medical technologies for older adults with complex medical diseases. Our long-term goals are to conduct epidemiologic research, create public health initiatives, and help shape policies that improve the lives of older adults.

Research Summary

Dr. Green’s research focuses on improving how older adults and their family caregivers make decisions about potentially harmful or unhelpful therapies.

PubMed

https://www.ncbi.nlm.nih.gov/pubmed?holding=jhumlib_fft_ndi&otool=jhumlib&term=green+ariel

Selected Publications

• Green AR, Aschmann H, Boyd CM, Schoenborn N. Patient-Preferred Language to Achieve Goal-Aligned Deprescribing in Older Adults: Results From a National Survey. JAMA Netw Open. 2021;4(4):e212633

• Green AR, Boyd CM, Gleason KS, Wright L, Kraus CR, Bedoy R, Sanchez B, Norton J, Sheehan OC, Wolff JL, Reeve E, Maciejewski ML, Weffald LA, Bayliss EA. Designing a Primary-Care Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: A Qualitative Study. J Gen Intern Med. 28 Jul 2020, 35(12):3556-3563

• Green AR, Lee P, Reeve E, Wolff J, Chen CCG, Kruzan R, Boyd CM. Clinicians’ perspectives on barriers and enablers of optimal prescribing in patients with dementia and coexisting conditions. J Am Board Fam Med. 2019 May-Jun;32(3):383-391

• Green AR, Reifler LM, Bayliss EA, Weffald LA, Boyd CM. Drugs contributing to anticholinergic burden and risk of fall or fall-related injury among older adults with mild cognitive impairment, dementia and multiple chronic conditions: A retrospective cohort study. Drugs Aging. 2019 Mar;36(3):289-297

• Green AR, Wolff JL, Echavarria DM, Chapman M, Phung A, Smith D, Boyd CM. How Clinicians Discuss Medications During Primary Care Encounters Among Older Adults with Cognitive Impairment. J Gen Intern Med. 2020 Jan;35(1):237-246

Honors

• Selected for U.S. Deprescribing Network Junior Investigator Intensive program, 1/1/20
• Inducted into Alpha Omega Alpha, 1/1/18
• Johns Hopkins Emerging Women's Leadership Program, 1/1/17
• Educational Program Award, Johns Hopkins Medicine Institute for Excellence in Education, 9/1/16
• Choosing Wisely Champion Award, American Geriatrics Society, 5/8/16
• David E. Rogers Award for professionalism, medical ethics, and community leadership, Johns Hopkins University School of Medicine, 1/1/08
• Sol Goldman Award for excellence in geriatrics, Johns Hopkins University School of Medicine, 1/1/08

Lectures & Presentations

• Choosing Wisely to improve care for geriatric patients: Recommendation 4. Do not use benzodiazepines or other sedative-hypnotics in older adults as first choice for insomnia, agitation or delirium, Speaker, American Geriatrics Society Annual Scientific Meeting plenary session, Grapevine, TX, 1/1/03
• The causes and consequences of overuse: Older adults' perspectives, Speaker, Lown Institute Conference, Boston, MA, 1/1/17
• What We Talk about When We Talk about Deprescribing: Pearls for Clinician Communication with Cognitively Impaired Older Adults and Their Caregivers, Speaker, American Geriatrics Society Annual Scientific Meeting, Portland, OR, 1/1/19

Graduate Program Affiliations

• Graduate Training Program in Clinical Investigation

Memberships

• American Geriatrics Society